Detalhe da pesquisa
1.
Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signalling.
Acta Neuropathol
; 142(3): 537-564, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34302498
2.
CD28.OX40 co-stimulatory combination is associated with long in vivo persistence and high activity of CAR.CD30 T-cells.
Haematologica
; 106(4): 987-999, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32381575
3.
GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma.
Clin Cancer Res
; 30(11): 2545-2557, 2024 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38551501
4.
Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We?
Front Immunol
; 12: 634031, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34163465
5.
Inclusion of the Inducible Caspase 9 Suicide Gene in CAR Construct Increases Safety of CAR.CD19 T Cell Therapy in B-Cell Malignancies.
Front Immunol
; 12: 755639, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34737753
6.
GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape.
J Immunother Cancer
; 9(3)2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33737337
7.
Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts.
J Immunother Cancer
; 9(6)2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34135100
8.
Adoptive Immunotherapy Using PRAME-Specific T Cells in Medulloblastoma.
Cancer Res
; 78(12): 3337-3349, 2018 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29615432